Evotec SE (EVO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov24

JPMorgan Increases Voting Rights in Evotec SE

09:41

Nov12

Evotec Receives $5 Million Milestone Payment from BMS and IND Application Accepted by FDA

10:02

Nov6

Evotec SE released FY2025 9 Months Earnings on November 5, 2025 (EST), with actual revenue of USD 609.11 M and EPS of USD -0.3817

04:00

Evotec SE released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 192.2 M (forecast USD 224.77 M), actual EPS USD -0.1422 (forecast USD -0.1954)

04:00

Nov5

Weston Analyzes and Recommends Healthcare Industry Stocks

09:26

Nov4

Evotec SE Signs Acquisition and Technology Licensing Agreement with Sandoz AG

21:07

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 192.2 M, Net Income -50.53 M, EPS -0.1422

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 200.44 M, Net Income -50.89 M, EPS -0.1433

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 216.47 M, Net Income -34.18 M, EPS -0.0962

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change